Ciprofibrate (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C10AB08
CAS registry number (Chemical Abstracts Service)
0052214-84-3
Chemical Formula
C13-H14-Cl2-O3
Molecular Weight
289
Therapeutic Category
Lipid lowering: Fibrate
Chemical Name
Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-metyl-
Foreign Names
- Ciprofibratum (Latin)
- Ciprofibrat (German)
- Ciprofibrate (French)
- Ciprofibrato (Spanish)
Generic Names
- Ciprofibrate (OS: USAN, DCF, BAN)
- Win 35833 (Winthrop) (IS)
- Ciprofibrate (PH: BP 2018, Ph. Eur. 9)
- Ciprofibratum (PH: Ph. Eur. 9)
Brand Names
- Alipidem
Iqfarma, Peru - Cerolip
Difare, Ecuador - Cetaxin
AC Farma, Peru - Cibrato
Mantecorp FSA, Brazil - Cipide
Aché, Brazil - Ciprofibraat Amdipharm
Amdipharm, Netherlands - Ciprofibrate
Concordia, United Kingdom; Zentiva, United Kingdom - Ciprofibrate Arrow
Arrow, France - Ciprofibrate Biogaran
Biogaran, France - Ciprofibrate Mylan
Mylan, Belgium; Mylan, France - Ciprofibrate Sandoz
Sandoz, France - Ciprofibrate Zentiva
Sanofi-Aventis, France - Ciprofibrato
Caferma, Peru; Sanofi-Aventis Farmaceutica, Brazil - Ciprofibrato Ache
Aché, Brazil - Ciprofibrato Biosintetica
Biosintética, Brazil - Ciprofibrato Farmandina
Farmandina, Guatemala - Ciprofibrato GeoLab
GeoLab, Brazil - Ciprofibrato La Santé
La Santé, Colombia; La Santé, Costa Rica; La Santé, Nicaragua; La Santé, El Salvador - Ciprofibrato Medley
Medley, Brazil - Ciprofibrato Merck
Merck, Brazil - Ciprofibrato MK
MK, Colombia - Ciprofibrato Neo Quimica
Neo Química, Brazil - Ciprofibrato PL
Paill, El Salvador - Ciprofibrato Vitamedic
Vitamedic, Brazil - Ciprolip
UCI-Farma, Brazil - Dislipen
Biogaran, Paraguay - Dublina
Pharma Investi de Chile, Chile - Espabinol
Panalab, Peru - Estabinol
Panalab, Peru - Estaprol
Sanofi Aventis, Chile; Sanofi-Aventis, Argentina; Sanofi-Aventis, Uruguay - Fibrolip
Garmisch, Colombia; Noas Farma, Uruguay - Fixeril
Lazar, Argentina; Lazar, Uruguay - Floxar SR
Joswe Medical, Lebanon - Giabri
Merck, Chile; Merck, Colombia; Merck, Ecuador; Merck, Peru - Hiperlipen
Sanofi, Dominican Republic; Sanofi, Guatemala; Sanofi, Panama; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Honduras; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Peru; Sanofi-Aventis, Paraguay; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Venezuela - Hyperlipen
Sanofi Belgium, Belgium - Hyperlipen-100
Sanofi Belgium, Luxembourg - Lipanor
CTS, Israel; Sanofi, Portugal; Sanofi Aventis, Tunisia; Sanofi Winthrop, Bulgaria; Sanofi Winthrop, Macedonia; Sanofi Winthrop, Serbia; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, France; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Poland - Lipanor 100 mg
Sanofi-Aventis, Hungary - Lipobrand
PharmaBrand, Ecuador - Lipodex
Unipharm, Guatemala; Unipharm, Honduras; Unipharm, Nicaragua; Unipharm, El Salvador - Lipofibrato
Maquifarma, Peru - Modalim
Sanofi Aventis, China; Sanofi Winthrop, Kuwait; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Singapore; Sanofi-Aventis Netherlands, Netherlands; Sanofi-Synthelabo, Lebanon - Oroxadin
Sanofi-Aventis, Mexico - Trifolget
Caferma, Peru
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.